Literature DB >> 33215492

Mucormycosis in the Jaw: A Report of 2 Cases and Literature Review.

Eun-Jung Kwak, Dong-Jin Kim, Woong Nam, Wonse Park.   

Abstract

Mucormycosis is a rare fungal infection with high morbidity and mortality and a very poor prognosis. However, aggressive medical and surgical management can result in survival rates exceeding 80%. The most common sites involved in mucormycosis infection are the sinus, lung, skin and soft tissues, gastrointestinal system, central nervous system, and rarely the mandible. Systemic risk factors for mucormycosis are diabetes mellitus (DM), neutropenia, corticosteroid use, hematologic malignancies, organ transplantation, metabolic acidosis, deferoxamine use, and advanced age. Local risk factors are a history of trauma, burns, surgery. We report on two patients with mucormycosis of the jaw. While one case presented as mucormycois involving the maxillary sinus in a patient with uncontrolled DM, the other was a rare case of mandibular mucormycosis in a patient with acute myeloid leukemia.

Entities:  

Keywords:  jaw; mucormycosis; necrosis; zygomycosis

Mesh:

Year:  2020        PMID: 33215492     DOI: 10.3290/j.ohpd.a45522

Source DB:  PubMed          Journal:  Oral Health Prev Dent        ISSN: 1602-1622            Impact factor:   1.256


  3 in total

1.  Post-COVID Mucormycosis of Mandible: A Conundrum of Management.

Authors:  Ashish Gopal; Raman Sharma; Sakshi Negi; Ishwar Singh
Journal:  Cureus       Date:  2022-07-28

2.  Mandibular mucormycosis following SARS-CoV-2 infection - A case report and review of literature.

Authors:  Aafiya Ambereen; Sajjad A Rahman; Suhailur Rehman; Kamran Zaidi; S H Arif
Journal:  Clin Infect Pract       Date:  2021-09-20

3.  A Rare Case of Mandibular Mucormycosis in a Post-COVID-19 Patient.

Authors:  Naqoosh Haidry; Kranti Bhavana; Peeyush Shivhare; Vivek Kumar; Aiswarya Vaidyanathan
Journal:  Cureus       Date:  2022-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.